Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating vitreous opacity

A technology of vitreous opacity and drugs, which is applied in the direction of drug combinations, pharmaceutical formulas, plant raw materials, etc., and can solve problems such as many complications, poor therapeutic effect, and decline

Inactive Publication Date: 2013-07-10
NANTONG HONGCI PHARMA
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Vitreous opacity is not an independent disease, but a common manifestation of many eye diseases. This disease sometimes develops rapidly, and the patient's vision rapidly declines to light perception, which brings great pain and inconvenience to life.
In addition, the vitreous itself has neither blood vessels nor nerves, and its metabolism is extremely slow. When turbidity occurs, the treatment effect is often not good
For patients with severe vitreous hemorrhage, only vitrectomy can be used, but there are many complications and easy loss of vision

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating vitreous opacity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Example 1, the weight ratio of raw materials: Gexianmi 6g, Angelica 8g, Dendrobium 8g, Guimu 6g, Qingzizi 6g, Rehmannia glutinosa 8g, Radix Paeoniae Alba 6g, Sangji 8g, Usnea 3g.

Embodiment 2

[0018] Example 2, the weight ratio of raw materials: Gexianmi 10g, Angelica 15g, Dendrobium 15g, Guimu 10g, Qingzizi 10g, Rehmannia glutinosa 15g, Radix Paeoniae Alba 10g, Sangji 15g, Usnea 6g.

Embodiment 3

[0019] Example 3, the weight ratio of raw materials: Gexianmi 8g, Angelica 10g, Dendrobium 10g, Guimu 8g, Qingzizi 8g, Rehmannia glutinosa 10g, Radix Paeoniae Alba 8g, Sangji 10g, Usnea 5g.

[0020] When in use, add water to decoct the traditional Chinese medicines Ge Xianmi, Angelica, Dendrobium, Guimu, Qingzizi, Rehmannia glutinosa, Radix Paeoniae Alba, Usnea and Sangjisheng twice, combine the filtrates, and take them in the morning and evening.

[0021] The effective combination and coordination of the above drugs can effectively achieve the purpose of treating vitreous opacity, and has less side effects. The above results are fully proved by the clinical data, and the relevant data are as follows, wherein the drug used in the study is the weight ratio of the bulk drug in Example 3.

[0022] 1 Objects and methods.

[0023] 1.1 Objects: From January 2009 to September 2011, 90 patients (133 eyes) had vitreous opacity caused by various reasons. Among them, there were 31 male...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating vitreous opacity, which can solve the treatment problem of vitreous opacity. The medicament is characterized by being processed from a variety of traditional Chinese medicines, and the formula comprises the following raw materials in parts by weight: 6-10 parts of nostoc sphaeroids kutz, 8-15 parts of Chinese angelica, 8-15 parts of dendrobium, 6-10 parts of Chinese trumpet creeper, 6-10 parts of feather cockscomb seed, 8-15 parts of radix rehmanniae preparata, 6-10 parts of white paeony root, 8-15 parts of Chinese taxillus twig and 3-6 parts of Chinese usnea. Clinical experiments prove that the medicament disclosed by the invention has the characteristics of good curative effect and higher safety for treating vitreous opacity and is worthy of clinical application and popularization.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating vitreous opacity. Background technique [0002] The normal vitreous body is a transparent gel body, which tends to degenerate with age, mainly manifested as condensation and liquefaction, that is, the transparent gel body in the vitreous body appears opaque, which is called vitreous opacities. It is a common eye disease in middle-aged and elderly people. The symptoms are smoke columnar or cloud-like dark shadows in the visual field, and the vitreous body is dusty, filamentous, flocculent, and cord-like cloudy. Vitreous opacity is not an independent disease, but a common manifestation of many eye diseases. This disease sometimes develops rapidly, and the patient's vision rapidly declines to light perception, which brings great pain and inconvenience to life. In addition, the vitreous itself has neither blood vessels nor nerves, and its metaboli...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8984A61P27/02
Inventor 修方伟
Owner NANTONG HONGCI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products